Research
Metabolic adaptation
Semaglutide treatment led to a weight decrease of 16 kg and a 36% reduction in insulin dose after 6 months in a patient with type 1 diabetes.
Semaglutide may be a beneficial treatment option for weight management in patients with type 1 diabetes.
StrongSupportsmedium confidence
After 6 months, weight had decreased by 16 kg and insulin dose by 36%.
Why this rating
The findings are based on a case study with clear outcomes.
Source
Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes
Lisa M. Raven et al. · JCEM Case Reports · 2022
case_studyCited 5×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →